Alba Ardevol
Overview
Explore the profile of Alba Ardevol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iborra I, Bartoli R, Bargallo A, Sunye S, Ardevol A, Fortuny M, et al.
Lab Anim
. 2025 Mar;
:236772241309760.
PMID: 40079644
BackgroundHistorically, preclinical studies with rat models have been carried out only with male animals. Current regulations require sex parity in experimental procedures. Several studies have shown significant sex differences in...
2.
Alvarado-Tapias E, Brujats A, Puente A, Ardevol A, Rodriguez-Arias A, Fajardo J, et al.
Hepatology
. 2024 Nov;
PMID: 39509369
Background And Aims: Carvedilol is a nonselective β-blocker (NSBB) with anti-α1-adrenergic activity, more effective than traditional NSBBs in reducing portal pressure hepatic venous pressure gradient (HVPG). However, 35%-45% of patients...
3.
Magaz M, Giudicelli-Lett H, Abraldes J, Nicoara-Farcau O, Turon F, Rajoriya N, et al.
J Hepatol
. 2024 Aug;
82(1):72-83.
PMID: 39181213
Background & Aims: Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine...
4.
Paternostro R, Kwanten W, Hofer B, Semmler G, Bagdadi A, Luzko I, et al.
J Hepatol
. 2024 Jun;
81(5):827-836.
PMID: 38823501
Background & Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of advanced chronic liver disease (ACLD). Portal hypertension drives hepatic decompensation and is best diagnosed by hepatic...
5.
Garcia-Guix M, Ardevol A, Sapena V, Alvarado-Tapias E, Huertas A, Brujats A, et al.
Liver Int
. 2024 Apr;
44(8):1971-1989.
PMID: 38634685
Background And Aims: Decompensated-cirrhosis encompasses several stages with different prognosis, such as bleeding, ascites and bleeding-plus-ascites. Development of further-decompensation worsens survival, while non-selective β-blockers (NSBBs) can modify the risk. However,...
6.
Fortuny M, Sarrias M, Torner M, Iborra I, Clos A, Ardevol A, et al.
Eur J Clin Invest
. 2023 Oct;
54(2):e14111.
PMID: 37849372
Background: Calprotectin is a calcium-binding-S100-protein synthetized mainly in neutrophils which has been demonstrated to be an accurate biomarker of the presence of these cells. Gut barrier dysfunction in patients with...
7.
Magaz M, Giudicelli-Lett H, Nicoara-Farcau O, Rajoriya N, Goel A, Raymenants K, et al.
Transplantation
. 2022 Dec;
107(6):1330-1340.
PMID: 36479977
Background: Porto-sinusoidal vascular liver disorder (PSVD) is a rare disease that occasionally requires liver transplantation (LT), despite usually presenting preserved liver function. There remains a paucity of data pertaining to...
8.
Masnou H, Aguilar A, Iborra I, Sala M, Torner M, Clos-Parals A, et al.
Gastroenterol Hepatol
. 2022 Sep;
46(4):288-296.
PMID: 36115630
Background: Bacterial infections remain one of the main complications in cirrhosis and worsen patients' prognosis and quality of life. An increase in multidrug resistant microorganism (MDRM) infections among patients with...
9.
Ventura-Cots M, Simon-Talero M, Poca M, Ariza X, Masnou H, Sanchez J, et al.
J Clin Med
. 2021 Nov;
10(21).
PMID: 34768404
Methods: (1) A randomized double-blind, placebo-controlled trial (BETA) was conducted in 12 hospitals. The effect of albumin (1.5 g/kg at baseline and 1 g/kg on day 3) on 90-day survival...
10.
Masnou H, Luna D, Castillo E, Galindo M, Ardevol A, Clos A, et al.
Gastroenterol Hepatol
. 2021 Jun;
45(6):424-431.
PMID: 34118317
Background: Acute-on-chronic liver failure (ACLF) is a common syndrome that occurs in patients with advanced chronic liver disease. It consists of the rapid failure of various organs and is associated...